2024³â ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦ 37Â÷ º½ Çмú´ëȸ(1ÀÏÂ÷) : 2024-04-05
±³À°ÀÏÀÚ : 2024-04-05
±³À°Àå¼Ò : ÆDZ³ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º ±¹Á¦È¸ÀǽÇ, Auditorium(´ë°´ç)
±³À°ÁÖÁ¦ : 2024³â ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦ 37Â÷ º½ Çмú´ëȸ(1ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇѼ¼Æ÷º´¸®ÇÐȸ
´ã´çÀÚ : ±èÀºÁ¤
¿¬¶ôó : 02-593-6943
À̸ÞÀÏ : cytopathology@hanmail.net
±³À°Á¾·ù : º´¸®°ú
Âü¼®¿¹»óÀÎ : 500¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª : °æ±âµµ
±³À°½Ã°£ : 6 ½Ã°£ 10ºÐ
¼¼ºÎ¼ö°·á : 100,000¿ø
ºñ°í Àü¹®ÀÇȸ¿ø 10¸¸¿ø / Àü°øÀÇ,Á¶±³,±ºÀÇ°üȸ¿ø 7¸¸¿ø / ¼¼Æ÷º´¸®»çȸ¿ø 7¸¸¿ø / ºñȸ¿ø 13¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04¿ù 05ÀÏ ÆDZ³ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º ±¹Á¦È¸ÀÇ½Ç 10:10~11:00 Ư°: WHO reporting systems in cytopathology, their rationale, process and progress so far Andrew Field(University of NSW and Notre Dame University Medical Schools & St Vincent¡¯s Hospital)
ÈÞ½Ä 04¿ù 05ÀÏ 11:00~11:10 Coffee break ( )
Åä·Ð 04¿ù 05ÀÏ ÆDZ³ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º ±¹Á¦È¸ÀÇ½Ç 11:10~11:50 Panel discussion: Application of WHO reporting systems in daily practice ä½Â¿Ï(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 04¿ù 05ÀÏ ÆDZ³ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º ±¹Á¦È¸ÀÇ½Ç 11:50~12:15 ½ÉÆ÷Áö¾ö ¥°A: Key diagnostic points in differential diagnoses of common salivary gland tumors ½Å¼öÁø(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 04¿ù 05ÀÏ ÆDZ³ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º ±¹Á¦È¸ÀÇ½Ç 12:15~12:40 ½ÉÆ÷Áö¾ö ¥°A: Updates in salivary gland cytology ¼ÛÁؼ±(¿ï»êÀÇ´ë)
ÈÞ½Ä 04¿ù 05ÀÏ 12:40~14:00 Á¡½É ( )
±³À°½Ã°£ 04¿ù 05ÀÏ ÆDZ³ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º ±¹Á¦È¸ÀÇ½Ç 14:00~14:30 Thyroid FNA Cytopathology of Non-papillary Thyroid Carcinomas ¼Õ°æÈñ(¼¿ï¾Æ»êº´¿ø)
±³À°½Ã°£ 04¿ù 05ÀÏ ÆDZ³ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º ±¹Á¦È¸ÀÇ½Ç 14:30~15:00 primary HPV test -an alternative to cytology smear, which is still inadequate Á¤Çý¶ó(°è¸íÀÇ´ë)
ÈÞ½Ä 04¿ù 05ÀÏ 15:00~15:10 Coffee break ( )
±³À°½Ã°£ 04¿ù 05ÀÏ ÆDZ³ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º ±¹Á¦È¸ÀÇ½Ç 15:10~15:35 ½ÉÆ÷Áö¾ö ¥°B: What to see in diagnosing lymph node cytology È«¶õ(Á¶¼±ÀÇ´ë)
±³À°½Ã°£ 04¿ù 05ÀÏ ÆDZ³ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º ±¹Á¦È¸ÀÇ½Ç 15:35~16:00 ½ÉÆ÷Áö¾ö ¥°B: Practical issues of ancillary studies in lymph node cytology ¹Ú¼öÈ£(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 04¿ù 05ÀÏ ÆDZ³ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º ±¹Á¦È¸ÀÇ½Ç 16:00~16:25 ¿¬ºÎÁ¶Á÷(Myxoid liposarcoma) °øÁؼ®(¿øÀÚ·ÂÀÇÇпø)
±³À°½Ã°£ 04¿ù 05ÀÏ ÆDZ³ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º ±¹Á¦È¸ÀÇ½Ç 16:25~16:50 ¸²ÇÁÀý(Burkitt lymphoma) ¹ÚÈñÁ¤(¼¼ºê¶õ½ºº´¿ø)
±³À°½Ã°£ 04¿ù 05ÀÏ ÆDZ³ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º ±¹Á¦È¸ÀÇ½Ç 16:50~17:15 Pleural fluid(EBV-positive nodal T- and NK-cell lymphoma) ±èÇö¼º(ÇѾç´ëº´¿ø)
±³À°½Ã°£ 04¿ù 05ÀÏ ÆDZ³ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º ±¹Á¦È¸ÀÇ½Ç 17:15~17:40 ³úô¼ö¾×(Malignant cell present, favor metastatic non-small cell carcinoma) ¹ÎÀç¿ë(°í´ë±¸·Îº´¿ø)
±³À°½Ã°£ 04¿ù 05ÀÏ ÆDZ³ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º ±¹Á¦È¸ÀÇ½Ç 17:40~18:00 ÃéÀå(Intrapancreatic accessory spleen) ÃÖ¼®Áø(ÀÎÇϴ뺴¿ø)